• Language
  • App
  • Subscriptions
  • Specials
  • Sign-In
  • Register
GeStepAhead Realasset Realasset
moneycontrol.com

Home » News » Recommendations

Apr 25, 2012, 11.00 AM | Source: Moneycontrol.com

Buy Persistent Systems; target of Rs 435: SPA Research

SPA Research is bullish on Persistent Systems and has recommended buy rating on the stock with a target of Rs 435 in its April 23, 2012 research report.

Like this story, share it with millions of investors on M3

Buy Persistent Systems; target of Rs 435: SPA Research

SPA Research is bullish on Persistent Systems and has recommended buy rating on the stock with a target of Rs 435 in its April 23, 2012 research report.

Post Your Comments

Share Cancel

(more)

, SPA Research |

SPA Research is bullish on Persistent Systems and has recommended buy rating on the stock with a target of Rs 435 in its April 23, 2012 research report.

“Persistent Systems came back strongly in the 4Q with a revenue growth of 4.9% QoQ and a solid margin expansion of 260bps QoQ, after a forgettable 3QFY12. This was mainly on the back of 38% sequential growth in the IP business. For FY12 PSYS crossed INR 10bn revenue for the first time, growing at 28.9%. We remain confident that the increased sales focus approach will help it maintain a sustained growth performance and thus expect a re-rating (8.0x FY13E and 6.8x FY14E EPS) to follow soon. We have increased the multiple (9x vs 8x previously) to our FY14E EPS of 48.4 and raise our TP to INR 435.”

“The company improved its Sales and Marketing focus, resulting in 35 new client additions to 288 and clients with more than $1mn revenue contribution jumping to 251 from 211 in the past 6 months. This was achieved with an incremental S&M spend of just 6%, thus not impacting its EBITDA margins which rose to 28.6% (highest in the company's history). The EBITDA Margin for FY12 was 23.2% up 280bps YoY. Margin expansion was primarily led by non-linear IP business which remains a strong margin lever for the company. PSYS FY12 revenue of $207.4mn was in-line with our estimates of $208.3mn and bang in the middle of the company's guidance of $205-$210mn registering a growth of 22.1%. The revenue of INR 10bn grew faster at 28.9% helped by dip in INR during the 2HFY12. Net Income of INR 1,417mn, however, beat our estimates of INR 1,306mn handsomely due to higher than expected margin improvement.”

“Steady growth especially from cloud and collaboration market of size $250bn and an improving margin profile, in our view, commands a revision of PSYS beaten-down PE multiple of 8.0x FY13E and 6.8x FY14E EPS. We value the stock at 9x our FY14E EPS of INR 48.4, thus continuing to recommend BUY with a TP of INR 435,” says SPA Research report.  

Institutional holding more than 40% in Indian cos

Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

To read the full report click here

Ads by Google

Buy, Hold, Sell ? Hear it first on M3
Buy Persistent Systems; target of Rs 435: SPA Research

See all

Get started using your favorite social network

or

Login using moneycontrol ID

Username
Password

Need help logging in? Reset password.

Don´t have an account? Sign Up

Get started using your favorite social network

or

Simply sign up using this short form

* mandatory

UserName*

Username should be atleast 4 character

Password*

Password should be 8 or more characters,
atleast 1 number, 1 symbol & 1 upper case letter

Alert

Your Password should contain
  • 8 or more characters
  • At least 1 number
  • At least 1 symbol
  • At least 1 upper case letter
Confirm Password*
Email
Already have an account? Login